Mallinckrodt PLC Company Profile (NYSE:MNK)

Analyst Ratings

Consensus Ratings for Mallinckrodt PLC (NYSE:MNK) (?)
Ratings Breakdown: 3 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Buy (Score: 2.81)
Consensus Price Target: $94.07 (41.47% upside)

Analysts' Ratings History for Mallinckrodt PLC (NYSE:MNK)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2016MizuhoBoost Price TargetBuy$80.00 -> $83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/19/2016BMO Capital MarketsReiterated RatingBuy$84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Goldman Sachs Group Inc.Initiated CoverageNeutral$73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016JPMorgan Chase & Co.Reiterated RatingNeutral$100.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Piper Jaffray Cos.Boost Price TargetOverweight$97.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2016Jefferies GroupReiterated RatingBuy$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016GuggenheimReiterated RatingBuy$98.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Northland SecuritiesReiterated RatingBuy$95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Leerink SwannBoost Price TargetOutperform$82.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016Nomura Holdings Inc.Reiterated RatingNeutral$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2015Deutsche Bank AGLower Price TargetBuy$89.00 -> $87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Barclays PLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2015Bank of America Corp.Lower Price TargetBuy$135.00 -> $131.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015CRT CapitalBoost Price TargetFairly Valued$84.00 -> $97.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014Buckingham ResearchBoost Price TargetBuy$107.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Keefe, Bruyette & WoodsReiterated RatingMarket Perform$90.00 -> $77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Mallinckrodt PLC (NYSE:MNK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2016Q216$1.72$2.01$878.70 million$918.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016Q116$1.77$2.00$888.33 million$915.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/23/2015Q415$1.77$1.84$869.41 million$882.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q315$1.82$2.05$983.81 million$965.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q215$1.48$1.72$860.89 million$909.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q115$1.55$1.84$880.12 million$866.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/19/2014Q414$1.41$1.68$759.04 million$789.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q314$0.87$1.20$278.80 million$653.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q214$0.78$0.95$566.50 million$557.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2014Q1$0.66$0.88$539.24 million$540.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013$0.85$1.02$572.57 million$552.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2013Q3 2013$0.78$0.49$557.22 million$570.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mallinckrodt PLC (NYSE:MNK)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 201610$1.64$1.87$1.77
Q2 20169$1.95$2.09$2.05
Q3 20163$1.98$2.14$2.04
Q4 20163$2.13$2.19$2.16
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Mallinckrodt PLC (NYSE:MNK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mallinckrodt PLC (NYSE:MNK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/10/2016Hugh M O'neillVPBuy1,653$60.99$100,816.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Matthew K HarbaughCFOBuy500$59.37$29,685.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Mark TrudeauCEOBuy1,000$56.02$56,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Steven J RomanoVPBuy900$56.00$50,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2016Coleman N Lannum IIIVPBuy2,600$62.63$162,838.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2016Meredith B FischerVPBuy1,400$69.80$97,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Coleman N Lannum IIIVPBuy600$59.66$35,796.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2016Coleman N Lannum IIIVPBuy1,300$62.58$81,354.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Matthew K. HarbaughCFOBuy1,300$63.00$81,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Coleman N. Lannum IIIVPBuy800$66.37$53,096.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2015Coleman N Lannum IIISVPBuy500$72.50$36,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Terrance L CarlsonGeneral CounselBuy1,000$69.10$69,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015Gary M. PhillipsVPBuy1,000$72.17$72,170.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2015Mark TrudeauCEOBuy1,350$65.89$88,951.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Coleman N Lannum IIISVPBuy1,200$66.86$80,232.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Meredith B FischerVPBuy2,200$66.93$147,246.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015Terrance L CarlsonGeneral CounselBuy1,000$66.54$66,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Hugh M O'neillSVPBuy1,197$83.52$99,973.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Mark TrudeauCEOBuy1,000$83.08$83,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Coleman N Lannum IIISVPBuy2,375$88.52$210,235.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Mark TrudeauCEOBuy2,000$88.45$176,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Coleman N Lannum IIIVPBuy1,300$126.41$164,333.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Matthew K HarbaughCFOSell22,106$128.64$2,843,715.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2015Mario D SaltarelliVPSell4,580$127.44$583,675.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015Don M BaileyDirectorSell51,417$122.45$6,296,011.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015Sandra L HattenVPSell2,024$122.29$247,514.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015Don M BaileyDirectorSell40,000$127.61$5,104,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Don M BaileyDirectorSell40,000$123.40$4,936,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Don M BaileyDirectorSell33,891$114.63$3,884,925.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Mark TrudeauCEOSell11,925$105.94$1,263,334.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Mark TrudeauCEOSell15,720$102.00$1,603,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014Peter G EdwardsVPSell1,265$99.69$126,107.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Mark TrudeauCEOSell13,831$93.59$1,294,443.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Raymond J FureyVPSell5,441$85.90$467,381.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Don M BaileyDirectorSell221,177$85.23$18,850,915.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Raymond J FureyVPSell15,000$85.47$1,282,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Virgil D ThompsonDirectorSell25,000$83.76$2,094,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Raymond J FureyVPSell10,303$81.61$840,827.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2014Raymond J FureyVPSell4,840$80.90$391,556.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Joseph A ZaccagninoDirectorBuy3,000$71.06$213,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Paulson & Co IncMajor ShareholderBuy132,100$69.80$9,220,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014J Martin CarrollDirectorBuy2,000$69.24$138,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Paulson & Co IncMajor ShareholderBuy467,900$68.78$32,182,162.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Paulson & Co IncMajor ShareholderBuy207,900$69.70$14,490,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Paulson & Co IncMajor ShareholderBuy700,200$70.15$49,119,030.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Paulson & Co IncMajor ShareholderBuy275,000$69.60$19,140,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014Melvin D BoothDirectorBuy4,000$76.05$304,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Paulson & Co Incmajor shareholderBuy786,207$73.63$57,888,421.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Mark TrudeauCEOSell14,890$56.12$835,626.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Mallinckrodt PLC (NYSE:MNK)
DateHeadline
07/22/16 05:06 PMInvestor Attention Turning to Mallinckrodt plc (NYSE:MNK) Stock - Engelwood Daily
07/22/16 05:06 PMMallinckrodt plc (NYSE:MNK): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 03:35 PMMALLINCKRODT PLC Files SEC form 8-K, Change in Directors or Principal Officers -
07/22/16 08:10 AMNew Broker Ratings For Mallinckrodt Plc (NYSE:MNK) - FTSE News
07/21/16 05:28 PMKingtone Wirelessinfo (KONE) Sudden Bullish Activity; Mizuho Sees Upside On Mallinckrodt (MNK)
07/21/16 08:05 AMAnalyst's Checklist Stocks: Community Health Systems, Inc. (NYSE:CYH) , Mallinckrodt plc (NYSE:MNK) - Street Updates
07/20/16 05:57 PMBullish Two Hundred Day Moving Average Cross - MNK
07/18/16 10:31 AMHC Stocks Reports Analysis: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Mallinckrodt PLC (NYSE:MNK) - share market updates (press release)
07/16/16 08:36 AMMallinckrodt plc (NYSE:MNK) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/16/16 08:36 AMLarge Inflow of Money Detected in Mallinckrodt plc - TheFounders Daily
07/15/16 09:39 AMAnalyst Target and Average Rating Watch: Mallinckrodt plc (NYSE:MNK) - Press Telegraph
07/15/16 09:39 AMBroker Outlook For Mallinckrodt Plc (NYSE:MNK) - Fiscal Standard
07/12/16 05:30 PMMallinckrodt plc (NYSE:MNK) Quarterly Accounts Payable At $118 Millions - RealistInvestor.com
07/11/16 05:15 PMWall Street Ratings and Target Price Views on Mallinckrodt plc (NYSE:MNK) - Telanagana Press
07/08/16 05:19 PMPerformance Recap and Target Perspective on Mallinckrodt plc (NYSE:MNK) - Press Telegraph
07/08/16 05:19 PMCompany Stock Focus for Mallinckrodt plc (NYSE:MNK): Which Way Will Shares Head? - Press Telegraph
07/08/16 05:19 PMCan Mallinckrodt plc (NYSE:MNK) Improve on the Earnings Front? - Engelwood Daily
07/08/16 05:19 PMMallinckrodt plc (MNK) : Analyst Rating Update - Trade Calls
07/07/16 07:15 AMProgenics Pharmaceuticals (PGNX) Jumps: Stock Up 9.3% -
07/06/16 05:26 PMStock Rating Watch and Earnings Insight for Mallinckrodt plc (NYSE:MNK) - Press Telegraph
07/06/16 05:26 PMMallinckrodt Plc (NYSE:MNK) Updated Price Targets - FTSE News
07/06/16 05:26 PMBMO Capital Initiates Coverage on Mallinckrodt PLC to Outperform - TheFounders Daily
07/06/16 05:26 PMIs it Finally Safe to Buy Mallinckrodt PLC (NYSE:MNK)? - Street Report
07/05/16 11:19 AMMallinckrodt Plc – Value Analysis (NYSE:MNK) : July 5, 2016 -
07/05/16 06:27 AM7:27 am Mallinckrodt announces new retrospective health economic data on H.P. Acthar Gel, a potential option for the management of multiple sclerosis relapses, has been published in Advances in Therapy -
07/05/16 06:05 AMHealth Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse - [PR Newswire] - CHESTERFIELD, United Kingdom, July 5, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on ...
07/04/16 07:19 AMMallinckrodt Plc breached its 50 day moving average in a Bullish Manner : MNK-US : July 4, 2016 -
07/02/16 04:55 PMShort Term Price Target on Mallinckrodt plc (MNK) - Trade Calls
07/01/16 05:15 PMHealthcare ratings roundup - new coverage #1
06/30/16 05:35 PMMallinckrodt PLC (NYSE:MNK) Institutional Investors Sentiment Index Worsens in Q1 2016 - Press Telegraph
06/30/16 05:35 PMEquity Research and Technical Review on Mallinckrodt plc (NYSE:MNK) - Press Telegraph
06/30/16 08:07 AMMallinckrodt Shares Rally As BMO Initiates At Outperform
06/29/16 05:06 PMAnalyst Upgrades: Symantec Corporation, Mallinckrodt PLC, and Transocean LTD
06/29/16 08:03 AMMallinckrodt plc (NYSE:MNK): Taking a look at the Consensus Estimates from Analysts - Telanagana Press
06/29/16 08:03 AMMallinckrodt plc (NYSE:MNK) Company Rating and Target Watch - Telanagana Press
06/29/16 08:03 AMShare Update and Earnings Review for Mallinckrodt plc (NYSE:MNK) - Press Telegraph
06/27/16 09:31 AMMallinckrodt Plc (NYSE:MNK) Broker Price Targets For The Coming Week - Fiscal Standard
06/26/16 04:30 PMMallinckrodt plc (NYSE:MNK) Stock Focus and Earnings Check - Engelwood Daily
06/25/16 09:00 AMAnalysts Trends to Watch: Thermo Fisher Scientific Inc (NYSE:TMO) , Mallinckrodt plc (NYSE:MNK) - Street Updates
06/25/16 09:00 AMMallinckrodt plc (NYSE:MNK) Earnings Glance and Target Price Review - Engelwood Daily
06/25/16 09:00 AMMallinckrodt PLC (NYSE:MNK) Scheduled Q3 Earnings Date - Street Report
06/22/16 05:06 PMMallinckrodt plc (NYSE:MNK) Analyst Rating Consensus - Trade Calls
06/21/16 04:52 PMBiotechnology Leads in Health Care
06/21/16 04:52 PMCommit To Buy Mallinckrodt At $30, Earn 11.7% Using Options
06/21/16 09:40 AMMallinckrodt plc To Report Third Quarter Fiscal 2016 Results On Aug. 2, 2016 - PR Newswire (press release)
06/20/16 01:00 PMMallinckrodt Needs More Medicine -
06/20/16 05:15 AMMallinckrodt Plc (NYSE:MNK) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 05:03 PMMallinckrodt : Donates One Million Drug Deactivation Pouches To Support U.S. Fight Against Prescription Drug Abuse
06/17/16 08:01 AMTraded Price Fluctuations to Observe: Mallinckrodt plc (NYSE:MNK) , XOMA Corporation (NASDAQ:XOMA) - Street Updates
06/16/16 05:23 PMTwo Buzzers to Observe: Mallinckrodt plc (NYSE:MNK) , United Therapeutics Corporation (NASDAQ:UTHR) - Street Updates

Social

About Mallinckrodt PLC

Mallinckrodt PLC logoMallinckrodt public limited company (Mallinckrodt) is engaged in the specialty pharmaceuticals and nuclear imaging business. The Company develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products, and nuclear imaging agents. The Company's segments include Specialty Brands, Specialty Generics and Nuclear Imaging. Its Specialty Brands segment produces and markets branded pharmaceutical and biopharmaceutical products for autoimmune and rare diseases; immunotherapy and neonatal respiratory critical care therapies, and central nervous system drugs. Its Specialty Generics segment produces specialty generic pharmaceuticals and active pharmaceutical ingredients (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its Nuclear Imaging segment manufactures and markets radiopharmaceuticals (nuclear medicine).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: MNK
  • CUSIP:
Key Metrics:
  • Previous Close: $66.49
  • 50 Day Moving Average: $61.10
  • 200 Day Moving Average: $62.47
  • P/E Ratio: 16.56
  • P/E Growth: 0.82
  • Market Cap: $7.22B
  • Beta: 1.5
  • Current Year EPS Consensus Estimate: $8.3 EPS
  • Next Year EPS Consensus Estimate: $8.88 EPS
Additional Links:
Mallinckrodt PLC (NYSE:MNK) Chart for Monday, July, 25, 2016